Marc Humbert
Overview
Explore the profile of Marc Humbert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
877
Citations
37416
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Issard J, Fadel E, Dolidon S, Gerardin B, Fabre D, Mitilian D, et al.
Pulm Circ
. 2024 Sep;
14(3):e12432.
PMID: 39234392
Balloon pulmonary angioplasty (BPA) to treat chronic thromboembolic pulmonary hypertension (CTEPH) is generally reserved for distal obstruction precluding pulmonary endarterectomy (PEA) but can be used in patients with proximal disease...
22.
Savale L, Tu L, Normand C, Boucly A, Sitbon O, Montani D, et al.
Eur Respir J
. 2024 Sep;
64(4).
PMID: 39227073
No abstract available.
23.
Guignabert C, Aman J, Bonnet S, Dorfmuller P, Olschewski A, Pullamsetti S, et al.
Eur Respir J
. 2024 Aug;
64(4).
PMID: 39209474
In recent years, major advances have been made in the understanding of the cellular and molecular mechanisms driving pulmonary vascular remodelling in various forms of pulmonary hypertension, including pulmonary arterial...
24.
Humbert M, Galie N, Rubin L, Simonneau G, McLaughlin V
Eur Respir J
. 2024 Aug;
64(4).
PMID: 39209470
No abstract available.
25.
Jambon-Barbara C, Hlavaty A, Bernardeau C, Bouvaist H, Chaumais M, Humbert M, et al.
ERJ Open Res
. 2024 Aug;
10(4).
PMID: 39135662
Introduction: Pulmonary arterial hypertension (PAH) is a rare and severe disease for which most of the evidence about prognostic factors, evolution and treatment efficacy comes from cohorts, registries and clinical...
26.
Gerges C, Beurnier A, Jais X, Herve P, Lau E, Girerd B, et al.
Chest
. 2024 Jul;
166(5):1173-1183.
PMID: 39059577
Background: Exercise hemodynamics are recommended for early detection of pulmonary arterial hypertension (PAH) and have been suggested to be predictive of future development of PAH in high-risk populations such as...
27.
Todesco A, Grynblat J, Akoumia K, Bonnet D, Mendes-Ferreira P, Morisset S, et al.
J Am Heart Assoc
. 2024 Jul;
13(14):e034621.
PMID: 38979789
Background: The primary genetic risk factor for heritable pulmonary arterial hypertension is the presence of monoallelic mutations in the gene. The incomplete penetrance of mutations implies that additional triggers are...
28.
Taille C, Humbert M, Bourdin A, Thonnelier C, Lajoinie A, Chassetuillier J, et al.
ERJ Open Res
. 2024 Jul;
10(4).
PMID: 38978545
https://bit.ly/49ixpxt.
29.
Boucly A, Bertoletti L, Fauvel C, Dewavrin M, Gerges C, Grynblat J, et al.
Respir Med Res
. 2024 Jul;
86:101123.
PMID: 38972109
Pulmonary hypertension (PH) continues to present significant challenges to the medical community, both in terms of diagnosis and treatment. The advent of the updated 2022 European Society of Cardiology (ESC)...
30.
Weatherald J, Hemnes A, Maron B, Mielniczuk L, Gerges C, Price L, et al.
Eur Respir J
. 2024 Jul;
64(3).
PMID: 38964779
The clinical classification of pulmonary hypertension (PH) has guided diagnosis and treatment of patients with PH for several decades. Discoveries relating to underlying mechanisms, pathobiology and responses to treatments for...